ROCKVILLE, Md., April 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) reported today that its trivalent seasonal influenza virus-like-particle (VLP)-based ...
VLP Law Group is a so-called virtual firm—meaning it has no office and minimal overhead—where all the work is corporate and almost all the lawyers are partners. The firm opened in 2008, just as the ...
Icosavax has raised a $51 million series A round to take respiratory syncytial virus (RSV) vaccine IVX-121 through phase 1b in older adults. The vaccine is built on computationally designed ...
SEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines ...
The Brooklyn Bar Association Volunteer Lawyers Project (VLP) held its annual Volunteer Recognition Event in Brooklyn Heights on Wednesday featuring a reception for all of its volunteers, with four of ...
Wataru Akahata, CEO of VLP Therapeutics Japan LLC, thinks he can help provide a solution to the challenge of securing COVID-19 vaccines for billions of people — the development of a second-generation ...
– No evidence of immune interference; initial indication of combinability achievable with company’s VLP technology – – Next steps: Icosavax plans to initiate a Phase 2 immunogenicity trial for IVX-A12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results